Cholestane-3β,5α,6β-Triol Inhibits Acid-Sensing Ion Channels and Reduces Acidosis-Mediated Ischemic Brain Injury
Stroke · 2024
DOI: 10.1161/strokeaha.124.046963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2024. Verfasst von Huawei Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA. Hauptthemen laut MEDLINE: Acid Sensing Ion Channels, Cricetulus, Acidosis, Mice, Knockout. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Activation of the acid-sensing ion channels (ASICs) by tissue acidosis, a common feature of brain ischemia, contributes to ischemic brain injury, while blockade of ASICs results in protection. Cholestane-3β,5α,6β-triol (Triol), a major cholesterol metabolite, has been demonstrated as an endogenous neuroprotectant; however, the mechanism underlying its neuroprotective activity remains elusive. In this study, we tested the hypothesis that inhibition of ASICs is a potential mechanism. METHODS: The whole-cell patch-clamp technique was used to examine the effect of Triol on ASICs heterogeneously expressed in Chinese hamster ovary cells and ASICs endogenously expressed in primary cultured mouse cortical neurons. Acid-induced injury of cultured mouse cortical neurons and middle cerebral artery occlusion–induced ischemic brain injury in wild-type and ASIC1 and ASIC2 knockout mice were studied to examine the protective effect of Triol. RESULTS: Triol inhibits ASICs in a subunit-dependent manner. In Chinese hamster ovary cells, it inhibits homomeric ASIC1a and ASIC3 without affecting ASIC1β and ASIC2a. In cultured mouse cortical neurons, it inhibits homomeric ASIC1a and heteromeric ASIC1a–containing channels. The inhibition is use-dependent but voltage- and pH-independent. Structure-activity relationship analysis suggests that hydroxyls at the 5 and 6 positions of the A/B ring are critical functional groups. Triol alleviates acidosis-mediated injury of cultured mouse cortical neurons and protects against middle cerebral artery occlusion–induced brain injury in an ASIC1a-dependent manner. CONCLUSIONS: Our study identifies Triol as a novel ASIC inhibitor, which may serve as a new pharmacological tool for studying ASICs and may also be developed as a potential drug for treating stroke.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Morehouse School of Medicine, Atlanta, GA.
ORCID-Profile: Huawei Sun, Zhi-Gang Xiong, Tiandong Leng
Förderung
- NINDS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Sun, H., Yang, T., Simon, R., Xiong, Z. G., & Leng, T. (2024). Cholestane-3β,5α,6β-Triol Inhibits Acid-Sensing Ion Channels and Reduces Acidosis-Mediated Ischemic Brain Injury. Stroke. https://doi.org/10.1161/strokeaha.124.046963
Vancouver
Sun H, Yang T, Simon R, Xiong ZG, Leng T. Cholestane-3β,5α,6β-Triol Inhibits Acid-Sensing Ion Channels and Reduces Acidosis-Mediated Ischemic Brain Injury. Stroke. 2024. doi:10.1161/strokeaha.124.046963
BibTeX
@article{Sun2024,
author = {Sun, Huawei and Yang, Tao and Simon, Roger and Xiong, Zhi-Gang and Leng, Tiandong},
title = {Cholestane-3β,5α,6β-Triol Inhibits Acid-Sensing Ion Channels and Reduces Acidosis-Mediated Ischemic Brain Injury},
journal = {Stroke},
year = {2024},
doi = {10.1161/strokeaha.124.046963}
}
EUVIMED